
Boston Scientific
Cancer Therapies and Ablation
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres: The DOSISPHERE-01 Trial
- 13 views
- February 17, 2021
Boston Scientific
The Changing Paradigm of Dosing and Dosimetry with Y90 Glass Microspheres in HCC
FEATURING
Shamar Young
- 30 views
- February 11, 2021
Boston Scientific
The Evolution of Dosimetry Using Y-90 Glass Microspheres
- 33 views
- November 24, 2020
Boston Scientific
Dosimetry Series: Multifocal Disease
FEATURING
Juan Gimenez
- 33 views
- November 24, 2020
Boston Scientific
Dosimetry Series: Radiation Segmentectomy
FEATURING
Ryan Hickey
- 34 views
- November 24, 2020
Boston Scientific
Dosimetry Series: Radiation Lobectomy
FEATURING
Robert Lewandowski
- 35 views
- November 24, 2020
Boston Scientific
LEGACY: A Multicenter Study Confirming TheraSphere™ as a Neoadjuvant or Standalone Therapy in Treating HCC
FEATURING
Vivian Bishay
- 404 views
- October 19, 2020
- 1
Boston Scientific
TheraSphere™ Y-90 Glass Microspheres: How it’s Made
- 108 views
- September 16, 2020
- 3
Boston Scientific
Evolution of the HCC Treatment: Clinical and Dosimetric Recommendations for Y-90
FEATURING
Riad Salem,
Etienne Garin
- 310 views
- September 2, 2020
Boston Scientific
Evolution of the HCC treatment: Optimized vs Standard Dosimetry
FEATURING
Etienne Garin
- 55 views
- September 9, 2020
Boston Scientific
Select Locoregional therapies as a COVID-19 Risk Mitigation treatment strategy for HCC
- 94 views
- September 2, 2020
- 1
Boston Scientific
Managing Interventional Oncology in the Time of Covid-19
- 47 views
- September 2, 2020
Boston Scientific
Long-term Outcomes of Liver Transplantation Following Y-90 Therapy as a bridge to transplant: a Multidisciplinary Approach
FEATURING
Riad Salem,
Talia Baker
- 205 views
- September 2, 2020
- 1
Boston Scientific
Cryoablation: A Tool to Expand your Renal Ablation Practice to Meet Expanding Indications
FEATURING
Andrew Gunn
- 68 views
- September 2, 2020
- 2
Boston Scientific
Advancing the Science in Lung Cryoablation
FEATURING
Matthew Callstrom
- 181 views
- September 2, 2020
- 1
Boston Scientific
LEGACY: A Multicenter Study Confirming TheraSphere as a Neoadjuvant or Standalone Therapy in Treating HCC
Oct. 19, 2020
Faculty:
Vivian Bishay
,
Boston Scientific
- 8 views
- October 19, 2020